Howard Hughes Medical Institute’s ExxonMobil XOM Stock Holding History

Howard Hughes Medical Institute’s Portfolio XOM Stock Details XOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-912	Closed	-$110K	–	488
2025 Q4	$110K	Sell	912 -4	-0.4%	-$464	0.06%	15
2025 Q3	$103K	Sell	916 -27	-3%	-$3K	0.06%	16
2025 Q2	$102K	Buy	+943	New	+$101K	0.04%	16

Other funds holding XOM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Howard Hughes Medical Institute's XOM Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of ExxonMobil (XOM) in Q1 2026, closing a stake of 912 shares — an estimated $110K sold.

Howard Hughes Medical Institute first reported a position in XOM in Q2 2025 and held it in 3 quarters. The position peaked at $110K in Q4 2025. 4,769 funds tracked by Wall St. Rank hold XOM as of Q1 2026.

Howard Hughes Medical Institute reported no remaining ExxonMobil position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 912 ExxonMobil shares in Q1 2026, an estimated $110K.
Howard Hughes Medical Institute first reported a position in ExxonMobil in Q2 2025 and held it in 3 quarters.
Howard Hughes Medical Institute's ExxonMobil position peaked at $110K in Q4 2025.
4,769 funds tracked by Wall St. Rank held ExxonMobil as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.